Vogenberg FR, Barash CI, Pursel M. Personalized medicine - Part 1: Evolution and development into theranostics. PT. 2010;35(10):560–76.
Aronson SJ, Rehm HL. Building the foundation for genomics in precision medicine. Nature. 2015;526(7573):336–42.
Article CAS PubMed PubMed Central Google Scholar
Golubnitschaja O, Kinkorova J, Costigliola V. Predictive, preventive and personalized medicine as the hardcore of “horizon 2020”: EPMA position paper. EPMA J. 2014;5(1):6.
Article PubMed PubMed Central Google Scholar
Mieda J, Ohaki Y, Oguro T, Shimizu H, Akasaka K, Kyomoto A, et al. Breast cancer with neuroendocrine differentiation detected by unique staining pattern of neoplastic cells in hercep test. J Nippon Med Sch. 2004;71(3):203–8.
Khoury MJ, Iademarco MF, Riley WT. Precision public health for the era of precision medicine. Am J Prev Med. 2016;50(3):398–401.
Frank M, Prenzler A, Eils R, von der Schulenburg JMG. Genome sequencing: a systematic review of health economic evidence. Health Econ Rev. 2013;3(1):29.
Article PubMed PubMed Central Google Scholar
Younesi E, Hofmann-Apitius M. From integrative disease modeling to predictive, preventive, personalized and participatory (P4) medicine. EPMA J. 2013;4(1):23.
Article PubMed PubMed Central Google Scholar
Garrod AE. The incidence of alkaptonuria: a study in chemical individuality. 1902 [classical article]. Yale J Biol Med. 2002;75(4):221–31.
PubMed PubMed Central Google Scholar
Stanley BA. The inborn factors in disease: an essay. J Am Med Assoc. 1931;97(16):1174.
Perlman RL, Govindaraju DR. Archibald E. Garrod: The father of precision medicine. Genet Med. 2016;18:1088–9.
Article CAS PubMed Google Scholar
Villa A, Sonis ST. System biology. Translational Systems Medicine and Oral Disease. Academic Press; 2020;9–16.
Hood L. Systems biology and P4 medicine: past, present, and future. Rambam Maimonides Med J. 2013;4.
Joyner MJ, Pedersen BK. Ten questions about systems biology. J Physiol. 2011;589:1017–30.
Article CAS PubMed PubMed Central Google Scholar
Chen R, Snyder M. Systems biology: personalized medicine for the future? Curr Opin Pharmacol. 2012;12(5):623–8.
Article CAS PubMed PubMed Central Google Scholar
Gifari MW, Samodro P, Kurniawan DW. Artificial intelligence toward personalized medicine. PSR. 2021;8:65–72.
Schork NJ. Artificial intelligence and personalized medicine. Cancer Treat Res. 2019;178:265–83.
Article CAS PubMed PubMed Central Google Scholar
Lipsitz LA. Physiological complexity, aging, and the path to frailty. Sci Aging Knowledge Environ. 2004;2004:16.
Hackner M, Lehle W. Predictive diagnostics solutions beyond big data. 2017; https://doi.org/10.1007/978-3-658-17109-4_12.
Bellavista P, Penna R della, Foschini L, Scotece D. Machine learning for predictive diagnostics at the edge: an IIoT practical example. IEEE Int Conf Commun 2020; https://doi.org/10.1109/ICC40277.2020.9148684.
Burden-Teh E, Murphy R, Gran S, Nijsten T, Hughes C, Abdul-Wahab A, et al. Identifying the best predictive diagnostic criteria for psoriasis in children (< 18 years): a UK multicentre case–control diagnostic accuracy study (DIPSOC study) *. Br J Dermatol. 2022;186:341–51.
Article CAS PubMed Google Scholar
Väänänen A, Haataja K, Vehviläinen-Julkunen K, Toivanen P. AI in healthcare: A narrative review. F1000Res. 2021;10:6.
Watanabe K, Aoki Y, Matsumoto M. An application of artificial intelligence to diagnostic imaging of spine disease: estimating spinal alignment from moiré images. Neurospine. 2019;16:697–702.
Article PubMed PubMed Central Google Scholar
Birkenbihl C, Emon MA, Vrooman H, Westwood S, Lovestone S, Hofmann-Apitius M, et al. Differences in cohort study data affect external validation of artificial intelligence models for predictive diagnostics of dementia - lessons for translation into clinical practice. EPMA J Springer Sci Bus Media Deutschland GmbH. 2020;11:367–76.
Jothi N, Rashid NA, Husain W. Data mining in healthcare - a review. Procedia Comput Sci. 2015;72:306–13.
Zhu S, Li Z, Cui L, Ban Y, Leung PCK, Li Y, et al. Activin A increases human trophoblast invasion by upregulating integrin β1 through ALK4. FASEB J John Wiley and Sons Inc. 2021;35:e21220.
Teama S. DNA Polymorphisms: DNA-based molecular markers and their application in medicine. In: Liu Y, editor. Genetic Diversity and Disease Susceptibility. London: IntechOpen; 2018
Domschke K. Targeted prevention of anxiety disorders. Eur Neuropsychopharmacol. 2021;46:49–51.
Article CAS PubMed Google Scholar
Cai Y, Yang J, Huang T, Wang MW. Editorial: Computational methods in predicting complex disease associated genes and environmental factors. Front Genet. 2021. https://doi.org/10.3389/fgene.2021.679651.
Article PubMed PubMed Central Google Scholar
Manolio TA, Bailey-Wilson JE, Collins FS. Genes, environment, and the value of prospective cohort studies. Nat Rev Genet. 2006;7:812–20.
Article CAS PubMed Google Scholar
Manolio TA. Genomewide association studies and assessment of the risk of disease. N Engl J Med. 2010;363:166–76.
Article CAS PubMed Google Scholar
Ogishima S, Nagaie S, Mizuno S, Ishiwata R, Iida K, Shimokawa K, et al. dbTMM: an integrated database of large-scale cohort, genome and clinical data for the Tohoku Medical Megabank Project. Hum Genome Var. 2021. https://doi.org/10.1038/s41439-021-00175-5.
Article PubMed PubMed Central Google Scholar
Ruisch IH, Dietrich A, Glennon JC, Buitelaar JK, Hoekstra PJ. Interplay between genome-wide implicated genetic variants and environmental factors related to childhood antisocial behavior in the UK ALSPAC cohort. Eur Arch Psychiatry Clin Neurosci. 2019;269:741–52.
Ikezaki H, Furusyo N, Nakashima R, Umemoto M, Yamamoto K, Matsumoto Y, et al. Kyushu and Okinawa population study (KOPS): a large prospective cohort study in Japan. BMJ Open BMJ Publ Group. 2021;11:e053763.
Gill D, Georgakis MK, Walker VM, Schmidt AF, Gkatzionis A, Freitag DF, et al. Mendelian randomization for studying the effects of perturbing drug targets. Wellcome Open Res. 2021;6:16.
Article PubMed PubMed Central Google Scholar
Yuan S, Carter P, Mason AM, Burgess S, Larsson SC. Coffee consumption and cardiovascular diseases: a Mendelian randomization study. Nutrients. 2021;13:2218.
Article CAS PubMed PubMed Central Google Scholar
Maharjan DT, Syed AAS, Lin GN, Ying W. Testosterone in female depression: a meta-analysis and mendelian randomization study. Biomolecules. 2021;11:409.
Article CAS PubMed PubMed Central Google Scholar
Plotkin SA, Plotkin SL. The development of vaccines: how the past led to the future. Nat Rev Microbiol. 2011;9:889–93.
Article CAS PubMed Google Scholar
DeMaria PJ, Bilusic M. Cancer vaccines. Hematol Oncol Clin North Am. 2019;33:199–214.
Kudrna JJ, Ugen KE. Gene-based vaccines and immunotherapeutic strategies against neurodegenerative diseases: potential utility and limitations. Hum Vaccin Immunother. 2015;11:1921–6.
Article PubMed PubMed Central Google Scholar
Fiore-Gartland A, Carpp LN, Naidoo K, Thompson E, Zak DE, Self S, et al. Considerations for biomarker-targeted intervention strategies for tuberculosis disease prevention. Tuberculosis (Edinb). 2018;109:61–8.
McCarthy PM, Clifton GT, Vreeland TJ, Adams AM, O’Shea AE, Peoples GE. AE37: a HER2-targeted vaccine for the prevention of breast cancer recurrence. Expert Opin Investig Drugs. 2021;30:5–11.
Article CAS PubMed Google Scholar
Bilkey GA, Burns BL, Coles EP, Bowman FL, Beilby JP, Pachter NS, et al. Genomic testing for human health and disease across the life cycle: applications and ethical, legal, and social challenges. Front Public Health. 2019;7:40.
Article PubMed PubMed Central Google Scholar
Bonetta L. Whole-genome sequencing breaks the cost barrier. Cell. 2010;141:917–9.
Article CAS PubMed Google Scholar
Mayeux R. Biomarkers: potential uses and limitations. NeuroRx. 2004;1:182–8.
Article PubMed PubMed Central Google Scholar
Parker LA, Chilet-Rosell E, Hernández-Aguado I, Pastor-Valero M, Gea S, Lumbreras B. Diagnostic biomarkers: are we moving from discovery to clinical application? Clin Chem. 2018;64:1657–67.
留言 (0)